CoChat

Efficacy of fenofibrate in Chinese patients with primary biliary cirrhosis partially responding to ursodeoxycholic acid therapy

Open access
HAN, Xiao Feng, WANG, Qi Xia, LIU, Yuan, YOU, Zheng Rui, BIAN, Zhao Lian, QIU, De Kai, MA, Xiong · 2012 · Journal of Digestive Diseases
Cited by 63

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To investigate the efficacy of fenofibrate combination therapy in Chinese patients with primary biliary cirrhosis (PBC) who had a partial response to standard dose of ursodeoxycholic acid (UDCA) for at least one year. METHODS: PBC patients were treated with UDCA (13–15 mg/kg/day) for more than one year. The biochemical response to UDCA treatment was evaluated after treatment. Fenofibrate (200 mg/day) was added to 22 patients with partial response to UDCA. RESULTS: In patients with partial response to UDCA, serum alkaline phosphatase (ALP) and γ‐glutamyl transpeptidase levels significantly decreased after 3‐month combination therapy of UDCA and fenofibrate, 68% of these patients even reached normal ALP level. Serum triglyceride (TG) and cholesterol levels were improved, and alanine transaminase (ALT) and aspartate transaminase (AST) were also decreased during the combination therapy. However, fenofibrate had no significant effect on serum bilirubin levels. The improvement of liver biochemical tests was maintained in some patients with long‐term therapy (at least 6 months). No obvious adverse effects were observed in patients taking fenofibrate. CONCLUSIONS: Fenofibrate is effective for improving liver biochemical tests in patients who have partial response to UDCA monotherapy. It is worth exploring the efficacy of fenofibrate on histological changes in PBC patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1751-2980.2012.00574.x

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 9

  1. 10.1016/j.jhep.2009.11.027 · DOI · Paper page
  2. 10.1111/j.1572-0241.2006.00634.x · DOI · Paper page
  3. Miyaguchi S, 2000, A novel treatment for refractory primary biliary cirrhosis?, Hepatogastroenterology, 47, 1518
  4. 10.3748/wjg.v10.i6.894 · DOI · Paper page
  5. 10.2174/1874192401004010120 · DOI · Paper page
  6. 10.1111/j.1572-0241.2002.05944.x · DOI
  7. 10.1002/hep.22670 · DOI
  8. 10.1042/bj3140781 · DOI · Paper page
  9. 10.1073/pnas.95.1.282 · DOI · Paper page

Cited by

See all 63

Metadata

Authors
HAN, X. F., WANG, Q. X., LIU, Y., YOU, Z. R., BIAN, Z. L., QIU, D. K., & MA, X.
Venue
Journal of Digestive Diseases
Publisher
Wiley
Published
2012-03-21
Volume
13
Issue
4
Pages
219-224
ISSN
  • 1751-2972 (ISSN-L)
  • 1751-2980
OpenAlex
W1539564928
Cited by
63
References
9
FWCI
2.84
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy of fenofibrate in Chinese patients with primary biliary cirrhosis partially responding to ursodeoxycholic acid therapy. https://app.cochat.ai/papers/10.1111/j.1751-2980.2012.00574.x
The paper
HAN, X. F., WANG, Q. X., LIU, Y., YOU, Z. R., BIAN, Z. L., QIU, D. K., & MA, X. (2012). Efficacy of fenofibrate in Chinese patients with primary biliary cirrhosis partially responding to ursodeoxycholic acid therapy. Journal of Digestive Diseases. https://doi.org/10.1111/j.1751-2980.2012.00574.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.